secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001104659-23-040233
Event type: debt
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics extends credit facility maturity to March 31, 2028
----------------------------------------------------------------------

- Extended maturity of $1.2B and $800M unsecured revolving credit facilities by one year to March 31, 2028.
- Extension effective March 31, 2023, per Section 2.7 of the Credit Agreement originally dated March 31, 2022.
- Facilities may be increased by up to $500M aggregate subject to commitments and conditions.
- No other changes to terms; borrowing capacity remains unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465923040233/0001104659-23-040233-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465923040233/tm2311145d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-040233

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer